Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 20,819 $ 20,528
Investments 8,203
Accounts receivable 35 65
Inventory 805 1,014
Prepaid expenses and other current assets 448 339
Related party receivable 18
Total current assets 22,107 30,167
Fixed assets, net 1,178 1,056
Right-of-use assets 766 1,021
Other non-current assets 13 13
Total assets 24,064 32,257
Current liabilities:    
Accounts payable and accrued expenses 2,333 2,999
Operating lease liabilities - current 238 321
Other current liabilities 60 270
Term debt, net of debt discount of $21 and $246, respectively 7,979 7,754
Total current liabilities 10,610 11,344
Contingent royalty obligation 1,617 1,872
Operating lease liabilities - non-current 547 713
Total liabilities 12,774 13,929
Commitments and contingent liabilities (Note 9)
Shareholders' equity    
Common Stock $0.0001 par value; 115,000,000 and 50,000,000 shares authorized as of December 31, 2020 and December 31, 2019, respectively; 32,272,309 and 28,811,087 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively 3 3
Additional paid-in capital 115,008 102,789
Accumulated deficit (103,721) (84,464)
Total shareholders' equity 11,290 18,328
Total liabilities and shareholders' equity 24,064 32,257
Preferred Series A Stock    
Shareholders' equity    
Preferred Stock $0.0001 par value; 8,000,000 shares authorized; zero shares issued and outstanding